Insider · CIK 0001186120

HANSON GREGORY P

Reports to the SEC for 2 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001186120

Forms 4 and 5

Insider transactions

39 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.M Exercise/Conversion	CHIEF FINANCIAL OFFICER, SECR	MExercise/Conversion	+7,021 sh	—	—	116,735
2018-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.F Tax Payment	CHIEF FINANCIAL OFFICER, SECR	FTax Payment	−2,428 sh	—	—	114,307
2018-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitM Exercise/Conversion	CHIEF FINANCIAL OFFICER, SECR	MExercise/Conversion	−7,021 sh	—	—	0
2018-02-21	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	CHIEF FINANCIAL OFFICER, SECR	AAward	+195K sh	—	—	195,000
2018-01-16	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	CHIEF FINANCIAL OFFICER, SECR	SSale	−41.9K sh	$0.92	−$38.5K	320,013
2018-01-12	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	CHIEF FINANCIAL OFFICER, SECR	SSale	−11.2K sh	$0.96	−$10.8K	361,886
2018-01-11	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	CHIEF FINANCIAL OFFICER, SECR	SSale	−38.7K sh	$0.98	−$37.9K	373,118
2018-01-10	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	CHIEF FINANCIAL OFFICER, SECR	SSale	−66.6K sh	$0.96	−$63.9K	411,815
2018-01-08	MABVAX THERAPEUTICS HOLDINGS, INC.M Exercise/Conversion	CHIEF FINANCIAL OFFICER, SECR	MExercise/Conversion	+449K sh	—	—	478,365
2018-01-08	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitM Exercise/Conversion	CHIEF FINANCIAL OFFICER, SECR	MExercise/Conversion	−449K sh	—	—	0
2017-10-02	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitA Award	CHIEF FINANCIAL OFFICER, SECR	AAward	+340K sh	—	—	340,420
2017-09-15	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitA Award	CHIEF FINANCIAL OFFICER, SECR	AAward	+109K sh	—	—	108,739
2017-05-19	MABVAX THERAPEUTICS HOLDINGS, INC.P Purchase	CHIEF FINANCIAL OFFICER, SECR	PPurchase	+4,286 sh	$1.75	+$7,500.5	33,492
2017-05-19	MABVAX THERAPEUTICS HOLDINGS, INC.P Purchase	CHIEF FINANCIAL OFFICER, SECR	PPurchase	+4,842 sh	—	—	38,334
2017-05-19	MABVAX THERAPEUTICS HOLDINGS, INC.Class A WarrantS Sale	CHIEF FINANCIAL OFFICER, SECR	SSale	−3,119 sh	—	—	0
2017-05-19	MABVAX THERAPEUTICS HOLDINGS, INC.Class B WarrantS Sale	CHIEF FINANCIAL OFFICER, SECR	SSale	−3,119 sh	—	—	0
2017-04-12	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	CHIEF FINANCIAL OFFICER, SECR	SSale	−3,885 sh	$2.00	−$7,770.389	29,206
2017-04-11	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	CHIEF FINANCIAL OFFICER, SECR	SSale	−200 sh	$2.00	−$400	33,091
2017-04-10	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	CHIEF FINANCIAL OFFICER, SECR	SSale	−400 sh	$2.00	−$800	33,291
2017-04-07	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	CHIEF FINANCIAL OFFICER, SECR	SSale	−450 sh	$2.00	−$902.25	33,691
2017-04-06	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	CHIEF FINANCIAL OFFICER, SECR	SSale	−867 sh	$2.15	−$1,861.883	34,141
2017-04-05	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	CHIEF FINANCIAL OFFICER, SECR	SSale	−1,800 sh	$2.15	−$3,872.34	35,008
2017-04-04	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	CHIEF FINANCIAL OFFICER, SECR	SSale	−1,000 sh	$2.25	−$2,250	36,808
2017-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.M Exercise/Conversion	CHIEF FINANCIAL OFFICER, SECR	MExercise/Conversion	+21.1K sh	—	—	37,808
2017-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitM Exercise/Conversion	CHIEF FINANCIAL OFFICER, SECR	MExercise/Conversion	−21.1K sh	—	—	21,063
2017-02-06	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	CHIEF FINANCIAL OFFICER, SECR	AAward	+75K sh	$2.99	+$224K	75,000
2017-01-01	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	CHIEF FINANCIAL OFFICER, SECR	AAward	+26.4K sh	$3.38	+$89.2K	26,400
2016-08-29	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	CHIEF FINANCIAL OFFICER, SECR	AAward	+26.4K sh	$5.00	+$132K	26,400
2016-08-17	MABVAX THERAPEUTICS HOLDINGS, INC.P Purchase	CHIEF FINANCIAL OFFICER, SECR	PPurchase	+3,119 sh	—	—	16,744
2016-08-17	MABVAX THERAPEUTICS HOLDINGS, INC.Class A WarrantP Purchase	CHIEF FINANCIAL OFFICER, SECR	PPurchase	+3,119 sh	—	—	3,119
2016-08-17	MABVAX THERAPEUTICS HOLDINGS, INC.Class B WarrantP Purchase	CHIEF FINANCIAL OFFICER, SECR	PPurchase	+3,119 sh	—	—	3,119
2016-04-04	MABVAX THERAPEUTICS HOLDINGS, INC.M Exercise/Conversion	CHIEF FINANCIAL OFFICER, SECR	MExercise/Conversion	+156K sh	—	—	158,867
2016-04-04	MABVAX THERAPEUTICS HOLDINGS, INC.F Tax Payment	CHIEF FINANCIAL OFFICER, SECR	FTax Payment	−58K sh	—	—	100,823
2016-04-04	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitM Exercise/Conversion	CHIEF FINANCIAL OFFICER, SECR	MExercise/Conversion	−156K sh	—	—	311,733
2016-02-16	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	CHIEF FINANCIAL OFFICER, SECR	AAward	+20K sh	$0.49	+$9,800	20,000
2015-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Buy Common StockA Award	CHIEF FINANCIAL OFFICER, SECR	AAward	+468K sh	$2.30	+$1.08M	467,600
2015-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitA Award	CHIEF FINANCIAL OFFICER, SECR	AAward	+468K sh	—	—	467,600
2014-12-16	MABVAX THERAPEUTICS HOLDINGS, INC.P Purchase	CHIEF FINANCIAL OFFICER, SECR	PPurchase	+3,000 sh	$2.50	+$7,500	3,000
2004-04-06	AVANIR PHARMACEUTICALS, INC.Incentive Stock Option (right to buy)A Award	Vice President, Finance	AAward	+10K sh	—	—	10,000

Recent filings

Accepted (ET)
Apr 34
HANSON GREGORY P0001415889-18-000538
SEC(opens sec.gov)
Feb 234
HANSON GREGORY P0001415889-18-000311
SEC(opens sec.gov)
Jan 184
HANSON GREGORY P0001415889-18-000080
SEC(opens sec.gov)
Jan 164
HANSON GREGORY P0001415889-18-000064
SEC(opens sec.gov)
Oct 44
HANSON GREGORY P0001415889-17-001619
SEC(opens sec.gov)
Sep 184
HANSON GREGORY P0001415889-17-001500
SEC(opens sec.gov)
Aug 24
HANSON GREGORY P0001415889-17-001296
SEC(opens sec.gov)
Apr 144
MABVAX THERAPEUTICS HOLDINGS, INC.0001415889-17-000640
SEC(opens sec.gov)
Apr 114
MABVAX THERAPEUTICS HOLDINGS, INC.0001415889-17-000635
SEC(opens sec.gov)

Companies

Address

11588 SORRENTO VALLEY ROAD, SUITE 20

SAN DIEGO, CA, 92121